Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China

We report the presence of the second human pegivirus (HPgV-2) in Guangdong and Sichuan Provinces in China. The prevalence of HPgV-2 in hepatitis C virus/HIV-1–co-infected persons who inject drugs was 12.9% in Guangdong and 15.9% in Sichuan. This population is at high risk for HPgV-2 infection.

Detalles Bibliográficos
Autores principales: Wang, Haiying, Wan, Zhengwei, Sun, Qiang, Zhu, Nalin, Li, Tianyi, Ren, Xuqi, An, Xiaoping, Deng, Shuyun, Wu, Yue, Li, Xiufen, Li, Lin, Li, Jingyun, Tong, Yigang, Tang, Shixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938795/
https://www.ncbi.nlm.nih.gov/pubmed/29664364
http://dx.doi.org/10.3201/eid2405.161162
_version_ 1783320847441723392
author Wang, Haiying
Wan, Zhengwei
Sun, Qiang
Zhu, Nalin
Li, Tianyi
Ren, Xuqi
An, Xiaoping
Deng, Shuyun
Wu, Yue
Li, Xiufen
Li, Lin
Li, Jingyun
Tong, Yigang
Tang, Shixing
author_facet Wang, Haiying
Wan, Zhengwei
Sun, Qiang
Zhu, Nalin
Li, Tianyi
Ren, Xuqi
An, Xiaoping
Deng, Shuyun
Wu, Yue
Li, Xiufen
Li, Lin
Li, Jingyun
Tong, Yigang
Tang, Shixing
author_sort Wang, Haiying
collection PubMed
description We report the presence of the second human pegivirus (HPgV-2) in Guangdong and Sichuan Provinces in China. The prevalence of HPgV-2 in hepatitis C virus/HIV-1–co-infected persons who inject drugs was 12.9% in Guangdong and 15.9% in Sichuan. This population is at high risk for HPgV-2 infection.
format Online
Article
Text
id pubmed-5938795
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-59387952018-05-15 Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China Wang, Haiying Wan, Zhengwei Sun, Qiang Zhu, Nalin Li, Tianyi Ren, Xuqi An, Xiaoping Deng, Shuyun Wu, Yue Li, Xiufen Li, Lin Li, Jingyun Tong, Yigang Tang, Shixing Emerg Infect Dis Dispatch We report the presence of the second human pegivirus (HPgV-2) in Guangdong and Sichuan Provinces in China. The prevalence of HPgV-2 in hepatitis C virus/HIV-1–co-infected persons who inject drugs was 12.9% in Guangdong and 15.9% in Sichuan. This population is at high risk for HPgV-2 infection. Centers for Disease Control and Prevention 2018-05 /pmc/articles/PMC5938795/ /pubmed/29664364 http://dx.doi.org/10.3201/eid2405.161162 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Wang, Haiying
Wan, Zhengwei
Sun, Qiang
Zhu, Nalin
Li, Tianyi
Ren, Xuqi
An, Xiaoping
Deng, Shuyun
Wu, Yue
Li, Xiufen
Li, Lin
Li, Jingyun
Tong, Yigang
Tang, Shixing
Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title_full Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title_fullStr Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title_full_unstemmed Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title_short Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China
title_sort second human pegivirus in hepatitis c virus–infected and hepatitis c virus/hiv-1–co-infected persons who inject drugs, china
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938795/
https://www.ncbi.nlm.nih.gov/pubmed/29664364
http://dx.doi.org/10.3201/eid2405.161162
work_keys_str_mv AT wanghaiying secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT wanzhengwei secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT sunqiang secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT zhunalin secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT litianyi secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT renxuqi secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT anxiaoping secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT dengshuyun secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT wuyue secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT lixiufen secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT lilin secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT lijingyun secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT tongyigang secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina
AT tangshixing secondhumanpegivirusinhepatitiscvirusinfectedandhepatitiscvirushiv1coinfectedpersonswhoinjectdrugschina

Ejemplares similares